Genentech Presents Data for Hemlibra at the ISTH 2019 Congress

The following is an excerpt from a press release from Genentech. Read the press release in its entirety here. Genentech, a member of the Roche Group, announced today new data for Hemlibra® (emicizumab-kxwh) across multiple pivotal studies in people with hemophilia A with and without factor VIII inhibitors at the International Society on Thrombosis and […]

uniQure Announces Follow-Up Data from Study in Patients with Hemophilia B

The following is an excerpt from a press release from uniQure. Read the press release in its entirety here. uniQure, a gene therapy company advancing transformative therapies for patients with severe medical needs, announced updated clinical data on the three patients treated in the company’s ongoing Phase IIb study of AMT-061, an investigational AAV5-based gene […]

Word From Washington: HFA Monitoring ACA Case

HFA continues to monitor the Texas v. United States case, in which a U.S. district court declared that the entire Affordable Care Act is unconstitutional by virtue of Congress’s 2017 repeal of the ACA’s individual mandate tax penalty. The district court ruling has been appealed by California and 19 other states, along with the U.S. […]